| 17.54 Data as of 3:59pm ET |  +0.92 / +5.54%Today’s Change | 15.13 Today|||52-Week Range 25.40 | -8.55% Year-to-Date |
| Ariad Stock Falls On Unusually High Volume (ARIA) May 16 / TheStreet.com | Ariad Posts Wider Y/Y Loss - Analyst Blog May 08 / Zacks.com |
| 10 ASCO '13 Abstracts You Can Read Right Now May 15 / TheStreet.com |
| Previous close | 16.62 |
| Today’s open | 16.71 |
| Day’s range | 16.68 - 17.58 |
| Volume | 3,400,540 |
| Average volume (3 months) | 2,991,519 |
| Market cap | $3.1B |
| Dividend yield | -- |
| Earnings growth (last year) | -44.09% |
| Earnings growth (this year) | -21.87% |
| Earnings growth (next 5 years) | -7.20% |
| Revenue growth (last year) | -97.79% |
| P/E ratio | NM |
| Price/Sales | 5,670.27 |
| Price/Book | 24.61 |
| Today’s change | Today’s % change | |
|---|---|---|
| CBSTCubist Pharmaceutica... | +1.98 | +3.70% |
| PRXLPAREXEL Internationa... | -0.20 | -0.43% |
| ISISIsis Pharmaceuticals... | +0.35 | +1.71% |
| CRLCharles River Labora... | +0.08 | +0.18% |
| Next reporting date | August 6, 2013 |
| EPS forecast (this quarter) | -$0.40 |
| Annual revenue (last year) | $558.0K |
| Annual profit (last year) | -$220.9M |
| Net profit margin | -39,582.80% |
Sector Health Technology |
Industry Biotechnology |
Chairman, President & Chief Executive Officer Harvey J. Berger, MD |
Senior VP-Corporate Development & Operations Pierre F. Dodion, MD, MBA |
Corporate headquarters Cambridge, Massachusetts |
.
